Shanghai Henlius Biotech, Inc. (HKG:2696)

Shanghai Henlius Biotech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	37,501	12,881	7,555	6,957	11,984	25,517
Market Cap Growth	230.14%	70.50%	8.59%	-41.95%	-53.03%	15.21%
Enterprise Value	40,457	16,522	11,112	10,233	13,635	25,011
Last Close Price	69.00	23.70	13.90	12.80	22.05	46.95
PE Ratio	41.52	14.75	12.56	-	-	-
Forward PE	40.02	15.91	12.55	-	-	-
PS Ratio	5.90	2.11	1.27	1.91	5.80	36.57
PB Ratio	10.04	4.02	3.13	3.76	4.25	6.72
P/TBV Ratio	-	-	-	-	25.87	12.46
P/FCF Ratio	22.40	11.23	11.94	15.51	-	-
P/OCF Ratio	19.43	9.75	6.54	6.27	108.01	-
EV/Sales Ratio	6.37	2.71	1.87	2.82	6.60	35.84
EV/EBITDA Ratio	29.04	13.36	10.82	-	-	-
EV/EBIT Ratio	43.13	17.92	15.45	-	-	-
EV/FCF Ratio	24.17	14.40	17.57	22.82	-	-
Debt / Equity Ratio	1.08	1.21	1.87	2.25	1.14	0.57
Debt / EBITDA Ratio	2.89	2.96	4.07	-	-	-
Debt / FCF Ratio	2.40	3.39	7.13	9.27	-	-
Net Debt / Equity Ratio	0.79	0.94	1.41	1.81	0.82	0.22
Net Debt / EBITDA Ratio	2.25	2.44	3.31	-7.06	-3.63	-0.84
Net Debt / FCF Ratio	1.77	2.63	5.37	7.48	-5.08	-0.60
Asset Turnover	0.54	0.56	0.57	0.40	0.25	0.10
Inventory Turnover	1.73	2.07	1.95	1.44	1.44	0.84
Quick Ratio	0.46	0.34	0.34	0.27	0.35	0.67
Current Ratio	0.68	0.50	0.53	0.44	0.56	0.97
Return on Equity (ROE)	27.54%	31.52%	28.52%	-35.35%	-35.81%	-27.60%
Return on Assets (ROA)	4.97%	5.28%	4.33%	-4.88%	-6.11%	-9.37%
Return on Invested Capital (ROIC)	13.69%	15.11%	12.67%	-14.32%	-16.48%	-29.95%
Return on Capital Employed (ROCE)	12.50%	15.60%	13.50%	-16.00%	-15.80%	-20.70%
Earnings Yield	2.41%	6.78%	7.96%	-11.30%	-10.08%	-4.62%
FCF Yield	4.46%	8.91%	8.37%	6.45%	-3.79%	-5.43%
Buyback Yield / Dilution	0.00%	-0.02%	-0.25%	-0.59%	-1.75%	-6.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.